172 related articles for article (PubMed ID: 32294036)
1. Recent Advances in Liposomal Drug Delivery System of Quercetin for Cancer Targeting: A Mechanistic Approach.
Das SS; Hussain A; Verma PRP; Imam SS; Altamimi MA; Alshehri S; Singh SK
Curr Drug Deliv; 2020; 17(10):845-860. PubMed ID: 32294036
[TBL] [Abstract][Full Text] [Related]
2. Intracellular ROS protection efficiency and free radical-scavenging activity of quercetin and quercetin-encapsulated liposomes.
Rezaei-Sadabady R; Eidi A; Zarghami N; Barzegar A
Artif Cells Nanomed Biotechnol; 2016; 44(1):128-34. PubMed ID: 24959911
[TBL] [Abstract][Full Text] [Related]
3. Novel self-emulsifying formulation of quercetin for improved in vivo antioxidant potential: implications for drug-induced cardiotoxicity and nephrotoxicity.
Jain S; Jain AK; Pohekar M; Thanki K
Free Radic Biol Med; 2013 Dec; 65():117-130. PubMed ID: 23792276
[TBL] [Abstract][Full Text] [Related]
4. Quercetin Loaded Nanoparticles in Targeting Cancer: Recent Development.
Vinayak M; Maurya AK
Anticancer Agents Med Chem; 2019; 19(13):1560-1576. PubMed ID: 31284873
[TBL] [Abstract][Full Text] [Related]
5. Application of Bioactive Quercetin in Oncotherapy: From Nutrition to Nanomedicine.
Nam JS; Sharma AR; Nguyen LT; Chakraborty C; Sharma G; Lee SS
Molecules; 2016 Jan; 21(1):E108. PubMed ID: 26797598
[TBL] [Abstract][Full Text] [Related]
6. Using superparamagnetic iron oxide nanoparticles to enhance bioavailability of quercetin in the intact rat brain.
Enteshari Najafabadi R; Kazemipour N; Esmaeili A; Beheshti S; Nazifi S
BMC Pharmacol Toxicol; 2018 Sep; 19(1):59. PubMed ID: 30253803
[TBL] [Abstract][Full Text] [Related]
7. Liposomal quercetin efficiently suppresses growth of solid tumors in murine models.
Yuan ZP; Chen LJ; Fan LY; Tang MH; Yang GL; Yang HS; Du XB; Wang GQ; Yao WX; Zhao QM; Ye B; Wang R; Diao P; Zhang W; Wu HB; Zhao X; Wei YQ
Clin Cancer Res; 2006 May; 12(10):3193-9. PubMed ID: 16707620
[TBL] [Abstract][Full Text] [Related]
8. Quercetin-loaded poly (lactic-co-glycolic acid)-d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles for the targeted treatment of liver cancer.
Guan X; Gao M; Xu H; Zhang C; Liu H; Lv L; Deng S; Gao D; Tian Y
Drug Deliv; 2016 Nov; 23(9):3307-3318. PubMed ID: 27067032
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a liposomal copper(II)-quercetin formulation suitable for parenteral use.
Chen KTJ; Anantha M; Leung AWY; Kulkarni JA; Militao GGC; Wehbe M; Sutherland B; Cullis PR; Bally MB
Drug Deliv Transl Res; 2020 Feb; 10(1):202-215. PubMed ID: 31482519
[TBL] [Abstract][Full Text] [Related]
10. Quercetin-phospholipid complex: an amorphous pharmaceutical system in herbal drug delivery.
Singh D; Rawat MS; Semalty A; Semalty M
Curr Drug Discov Technol; 2012 Mar; 9(1):17-24. PubMed ID: 21644920
[TBL] [Abstract][Full Text] [Related]
11. Comparing different sterol containing solid lipid nanoparticles for targeted delivery of quercetin in hepatocellular carcinoma.
Varshosaz J; Jafarian A; Salehi G; Zolfaghari B
J Liposome Res; 2014 Sep; 24(3):191-203. PubMed ID: 24354715
[TBL] [Abstract][Full Text] [Related]
12. Nano Drug Delivery Strategies for an Oral Bioenhanced Quercetin Formulation.
Attar ES; Chaudhari VH; Deokar CG; Dyawanapelly S; Devarajan PV
Eur J Drug Metab Pharmacokinet; 2023 Sep; 48(5):495-514. PubMed ID: 37523008
[TBL] [Abstract][Full Text] [Related]
13. Development of quercetin-phospholipid complex to improve the bioavailability and protection effects against carbon tetrachloride-induced hepatotoxicity in SD rats.
Zhang K; Zhang M; Liu Z; Zhang Y; Gu L; Hu G; Chen X; Jia J
Fitoterapia; 2016 Sep; 113():102-9. PubMed ID: 27431774
[TBL] [Abstract][Full Text] [Related]
14. Effects of Quercetin-Loaded Nanoparticles on MCF-7 Human Breast Cancer Cells.
Niazvand F; Orazizadeh M; Khorsandi L; Abbaspour M; Mansouri E; Khodadadi A
Medicina (Kaunas); 2019 Apr; 55(4):. PubMed ID: 31013662
[No Abstract] [Full Text] [Related]
15. [Research and application of quercetin-loaded nano drug delivery system].
Li SJ; Liao YF; Du Q
Zhongguo Zhong Yao Za Zhi; 2018 May; 43(10):1978-1984. PubMed ID: 29933659
[TBL] [Abstract][Full Text] [Related]
16. Co-encapsulation of tamoxifen and quercetin in polymeric nanoparticles: implications on oral bioavailability, antitumor efficacy, and drug-induced toxicity.
Jain AK; Thanki K; Jain S
Mol Pharm; 2013 Sep; 10(9):3459-74. PubMed ID: 23927416
[TBL] [Abstract][Full Text] [Related]
17. Drug delivery based pharmacological enhancement and current insights of quercetin with therapeutic potential against oral diseases.
Wang Y; Tao B; Wan Y; Sun Y; Wang L; Sun J; Li C
Biomed Pharmacother; 2020 Aug; 128():110372. PubMed ID: 32521458
[TBL] [Abstract][Full Text] [Related]
18. Research Progress of Quercetin Delivery Systems.
Zhao X; Deng Y; Xue X; Liao L; Zhou M; Peng C; Li Y
Curr Pharm Des; 2022; 28(9):727-742. PubMed ID: 35301946
[TBL] [Abstract][Full Text] [Related]
19. Liposomes, lipid nanocapsules and smartCrystals®: A comparative study for an effective quercetin delivery to the skin.
Hatahet T; Morille M; Hommoss A; Devoisselle JM; Müller RH; Bégu S
Int J Pharm; 2018 May; 542(1-2):176-185. PubMed ID: 29549014
[TBL] [Abstract][Full Text] [Related]
20. Dual drug delivery of tamoxifen and quercetin: Regulated metabolism for anticancer treatment with nanosponges.
Lockhart JN; Stevens DM; Beezer DB; Kravitz A; Harth E
J Control Release; 2015 Dec; 220(Pt B):751-7. PubMed ID: 26344396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
